Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Western Blot Products
  4. General Western Blot Reagents
  5. 502705090

Abcam Bufalin, Na+/K+-ATPase Inhibitor, Solid, >98% Purity, 50 mg

Catalog No. 502705090
Encompass_Preferred
Change view
Click to view available options
Quantity:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-270-5090 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-270-5090 Supplier Abcam Supplier No. AB14563650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Description

Potent Na+/K+-ATPase inhibitor that induces cell differentiation and apoptosis.

  • Molecular Weight: 386.5 Da
  • Purity: >98%
  • Form: Solid
  • Mechanism of Action: Na+/K+-ATPase inhibitor; potent inhibitor of steroid receptor coactivators SRC-3 and SRC-1
  • Biological Activity: Induces cell differentiation and apoptosis; activates AP-1 via JNK; shows antitumor effects in vivo
  • Composition: 100% 3β-14-Dihydroxy-5β-bufa-20,22-dienolide

Specifications

Content And Storage Store at -20°C.
Form Solid
Shipping Condition Ambient
Substrate Properties Chemical Substrate
Buffer 100% 3β-14-dihydroxy-5β-bufa-20,22-dienolide
Target Molecule Na+/K+-ATPase, SRC-3, SRC-1
Formulation 100% 3β-14-Dihydroxy-5β-bufa-20,22-dienolide
Quantity 50 mg
For Use With (Application) Na+/K+-ATPase inhibition, SRC-3 and SRC-1 inhibition, Induction of cell differentiation and apoptosis, AP-1 activation
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.